Status:
COMPLETED
Tele-Rehabilitation in Individuals With Covid-19
Lead Sponsor:
Hacettepe University
Conditions:
COVID-19
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Coronavirus Disease (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-cov-2). This study was planned as a single-blind randomized controlled pilot stu...
Eligibility Criteria
Inclusion
- A score in the range of 0-3 on the MRC Dyspnea Scale.
- Not have any vestibular, orthopedic or neurological disease that will affect muscle strength, balance and coordination.
- Not having undergone surgery in the last 6 months.
- Not having undergone any surgical procedure that may affect the musculoskeletal system of the spinal column, lower extremities or upper extremities.
- It was being cooperative and volunteering.
Exclusion
- Severe liver and kidney disease or new and progressive damage to liver and kidney function, deep vein thrombosis and pulmonary embolism, suspected aortic stenosis, having a disease/condition for which exercise is contraindicated.
Key Trial Info
Start Date :
April 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05305638
Start Date
April 15 2022
End Date
October 15 2022
Last Update
January 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Ankara, Turkey (Türkiye)